Ligand Pharmaceuticals (NasdaqGM:LGND) 2025 Investor Day Transcript
Ligand(US:LGND)2025-12-09 16:32Ligand Pharmaceuticals (NasdaqGM:LGND) 2025 Investor Day December 09, 2025 10:30 AM ET Company ParticipantsJoe Pantginis - Managing Director of Equity ResearchAnnabel Samimy - Managing Director of Equity ResearchMelanie Herman - Head of Investor RelationsScott Plesha - CEOTavo Espinoza - CFOTodd Davis - CEOKaren Reeves - SVP of Investments and Head of Clinical StrategyRich Baxter - SVP of Investment OperationsLauren Hay - VP of Strategic Planning and Investment AnalyticsPaul Hadden - SVP of Investments and ...